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SUMMARY
The Thy-1 gene is expressed in a tissue- and stage-specific
pattern and has a typical 1.6kb methylation-free island (MFI) covering
about 600bp upstream and downstream of the two alternative first exons. By
microinjection of a mouse Thy-1.1/human Thy-1 gene into fertilized eggs, we
were able to show that the MFI is restored in the transgenic mice. The
flanking sequence became methylated, but the MFI remains unmethylated in
all tissues of transgenic mice at different developmental stages tested,
irrespective of the site of expression of the gene. There is one
exception, in extra-embryonal tissues of 14.5 day embryos a small
percentage of the islands were methylated. We conclude that maintenance of
the MFI is regulated by cis-acting sequences present within the gene, and
indicates that the unmethylated state of the islands is consistent with a
necessary but not sufficient condition for expression of the gene.
INTRODUCTION
The dinucleotide CpG is 4-5 fold under-represented in the
vertebrate genome, but accounts for almost all of the methylcytosine
present. Between 60% and 90% of CpGs are methylated at the 5-position on
the pyrimidine ring. This modification renders vertebrate DNA less
cleavable by certain restriction endonucleases that are inhibited when this
doublet is methylated. The bulk of mammalian DNA is highly methylated, but
Cooper et al. (1) described that about 1% of the vertebrate genome was
frequently cut by HhaI and HpaII, both of which are methylation sensitive.
Recently, it has been shown that these sites are clustered and that there
are about 30,000 of these CpG-rich, methylation-free islands in the haploid
genome (2). They were found in all tissues investigated and their sequences
are, for the most part, unique. Several genes, mainly housekeeping genes,
have been reported to have such methylation-free islands, covering
500-2000bp at their 5' end. They frequently include the first exon(s) as
well as upstream sequences (see review (3)). At present the role of these
islands in the control of gene expression is not clear, nor is it known how
an MFI is maintained.
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The Thy-1 gene is a member of the immunoglobulin superfamily
of genes (4) and is expressed in a highly tissue specific and
developmentally regulated manner (see review (5)). The mouse Thy-1 gene (6)
has a CpG-rich 5' region which is a methylation-free island (7), and covers
two very unusual promoters (6-9). Here we describe a study on the
maintenance of the methylation pattern of the Thy-1 gene, by studying the
methylation pattern of a mouse-human hybrid gene, introduced into the germ
line of mice. The hybrid gene was made up from the 5' part of the murine
Thy-1 .1 gene and the 3' untranslated part of the human Thy-1 gene, to allow
clear distinction of the introduced hybrid gene and its products from the
endogenous Thy-1 .2 background.
We show that in all transgenic mice and their offspring, the
island was reformed in all tissues, whether the construct was highly
expressed or not, and whether a few or multiple copies of the gene were
inserted at any one locus. The only exception to the maintenance of the
MFI was a slight degree of methylation of the island in extra-embryonic
foetal tissue (placenta and yolk sac).
MATERIALS AND METHODS
(CBA/J x C57Bl/lO)Fl mice were bred at NIMR, London.
Restriction enzymes were obtained from Anglian Biotechnology, Colchester,
Essex, U.K., Bio-Labs, Beverly, MA, USA, Bethesda Research Laboratories,
Bethesda, MD, USA and Boehringer, Mannheim, Germany. Isotopes were from
New England Nuclear, UK.
Construction of hybrid genes and microiniection
A mouse-human Thy-1.1 hybrid gene was constructed by
replacement of the non-coding part of the murine gene by the human
equivalent (1O). A 9.2kb EcoRI fragment of the hybrid gene was injected
into the pronuclei of fertilized eggs from (CBAxC57 B1/10)F1 mice as
described previously (11).
DNA methylation
Genomic DNA from various organs of normal and transgenic
embryos or adult mice was cut with 5-10-fold excess restriction enzymes.
This was necessary to obtain complete digestion with the enzymes SacI,
MBpI, HpaII and haI, and was monitored by the addition of an internal X
DNA control. The fragments were analyzed by Southern blotting (23) using
0.8 or 1.0% agarose gels. The probes were prepared from the gene construct
and labelled with PdTTP and PdATP using Klenow fragment and a
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hexadeoxyribonucleotide mixture (Pharmacia, Uppsala, Sweden) as described
(12).
RESULTS
Transgenic mice
The hybrid gene construct consisted of a 6kb fragment from
the 5' part of the 9.2 kb cloned Thy-1.1 (AIR) mouse gene (6). This
fragment contained the first four exons (Ia and b, II, III in Fig. 1) and
the 5' end of exon IV coding for the transmembrane part of the protein and
about 10 bases of the 3' untranslated region. Linked to it was 3.2kb of the
human Thy-1 gene (13) containing the remaining part of exon IV, i.e. the
major part of the 3' untranslated region and 2kb of the 3' flanking
sequence. The gene was injected as a 9.2kb EcoRI fragment, as previously
described (11).
Four transgenic mice were identified in a litter of 13
newborn mice by tail DNA blots. The first mouse (Tg6) died before mating
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Fit. 1:
a) The mouse human gene construct of Thy-1.
The exons I-IV and the probes used for the Southern blot anlysis are
indicated. A: ApaI, B: BglII, E: EcoRI, N: NcoI, P: PstI, S: SacI.
The solid blocks represent mouse exon sequences, the open block human
exon seqences.
b) The sites for MspI/HpaII are indicated by upwards bars and the sites
for HhaI by downwards bars. Methylated sites are indicated with
filled circles and partly methylated sites with open circles. Simple
bars indicate unmethylated sites. The MspI sites and the HhaI sites
are referred to in the text by numbers assigned from the 5' end (1-16
for MspI sites and 1-11 for HhaI sites). These were obtained by
using the sequence of the mouse Thy-1 .2 gene (6,8,24) and restriction
digests of the Thy-1.1 construct.
9669
3'
Nucleic Acids Research
Sac
Hpa Msp I H-ha
1 23 4 56 1 23 4 56 1 23 4 56 1 23 456
4422-
2002-
~~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~
-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
...
396-~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~......
s NAf sg
waseused foahBridiztwion. SaX DnA(ietdwithMsIHpIoidr Hand pBR322catdNA
(digested with Hinf I) were used as markers.
9670
Nucleic Acids Research
and was only partially analyzed, but showed essentially the same results as
the other mice. Founder mice Tg9, Tg1l and Tg12 contained 20, 20 and 60
copies of the Thy-1 gene, respectively. Southern blotting showed that the
genes were integrated in a head to tail concatamer (see below and Fig. 4).
Very little DNA was lost during the integration of the exogenous DNA, since
50% of the inserted copies still contained the terminal EcoRI sites, while
all copies retained all other restriction sites (data not shown).
Mapping of Potential methylation sites in the gene construct
Most of the sequence of the mouse Thy-1.2 and the human Thy-1
genes is known (6,8,14,24). The murine Thy-1.1 and Thy-1 .2 sequences show
several differences in their non-coding regions (6) and the HpaII and Hhal
sites in the constructed gene were therefore mapped by restriction fragment
analysis. The construct contained a total of 16 Msp sites and 11 HhaI
sites, of which 14 (7 for MspI and 7 for HhaI) are clustered in a 5' 1.6 kb
fragment surrounding exons Ia and Ib (Fig. lb). This region contains the
MFI and has a high CG dinucleotide frequency (6,7). The remainder of the
gene has a low CG frequency as described for the bulk of DNA (2). We have
nmbered the MspI (1-16) and HhaI (1-11) sites in the hybrid gene, starting
from the 5' end.
Methvlation Pattern
Sac I-digested genomic DNA from transgenic mice was
redigested with the methylation sensitive enzymes HpaII and HhaI or the
methylation insensitive enzyme MspI as a control and Southern blotted. The
blots were hybridized with different radioactively labelled probes as
indicated in Fig.1. When probes 1 or 2 were used, a SacI fragment of 4.3kb
was detected indicating a head-to-tail arrangement of the tandemly inserted
genes in Tgl2 offspring (Fig. 2). Double digestion with HpaII or HhaI
showed the presence of a methylation-free island in the 5' part of the
construct gene. The HpaII digest showed an almost identical pattern to the
MspI digests. The largest fragment from the promoter region hybridizing to
probe 1 was 460 bp, similarly, small fragments were seen in the HhaI
digests (Fig. 2). Only a very faint band corresponding to a fragment of
about 560bp was noticed after HpaII digestion, which shows a slight degree
(<10%) of methylation of MBpI site no.6. This site might therefore
represent the 3' border of the MFI in the transgenic mice.
Further downstream in the mouse part of the construct, very
few sites for MspI/HpaII and HhaI are available and these sites were fully
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Fig. 3:
Southern blot analysis of DNA from transgenic mouse (Tgl2) tissues.
The lanes were as in Fig. 2. Probe no. 5 was used for
hybridization.
or partially methylated using probes 2, 3, 4, 5 and 6 (Msp/HpaII sites 8-11
and HhaI sites 8 and 9, see Fig. ib).
For example, Fig. 3 shows a blot of the very 3' end of the
constructed gene with probe 5. Since multiple copies of the gene are
inserted in a head to tail configuration, the digest gives rise to the
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Southern blot analysis of DNA from 14.5 day embryos of transgenic
mouse (Tg12). The DNA was cut with SacI and with MspI, HpaII or HhaI as
indicated. 5pg DNA was used for each lane.
a) Lane 1: brain, lane 2: yolk sac, lane 3: muscle, lane 4: liver.
b) Lane 1: yolk sac, lane 2: brain.
c) Reprobing of blot b with probe 4.
Blots a and b show the same methylation in the yolk sac. Reprobing
of blot b excludes that the methylation pattern was due to partial cutting
with SacI.
4.3kb Sac I fragment containing the 3' end of one copy linked to the 5' end
of the next. Methylation of the sites in the 3' end of the construct, and
non-methylation of the sites in the 5' end (WPI part) of the construct
would be expected to yield a 2.7kb fragment with HhaI and a 2.3 kb fragment
with HpaII. These fragments were indeed observed (Fig. 3), indicating that
the two MspI sites (nos. 15 and 16, Fig. ib) were fully methylated and
confirming that MspI site no. 1 and the HhaI sites nos. 1 and 2 are the
first measurable sites at the 5' border of the MFI which are unmethylated.
The island, including the faint methylation of MBpI site no.6
appeared to be fully conserved in all the gene copies in all the tissues of
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Fig. 5:
Expression of the Thy-1 transgene in adult mice.
Total RNA was extracted from 8 week old transgenic brain (lane 1),
thymus (lane 2) and spleen (lane 3). The 3' termini of the hybrid mouse
human Thy-1 transgenic RNA and the endogenous Thy-1.2 RNA were mapped by
Si nuclease using either a 950bp 3' labelled NcoI/BglII human probe or a
680bp 3' labelled BamHi/BamHi mouse Thy-1 .2 probe. The sizes of the
protected fragments are as expected (6,14). In the case of the human
Thy-1 RNA termination is shown to occur in two sites. Sizes were
estimated using 5' end labelled fragments of pBR322 x HinfI digest.
all the transgenic mice investigated, with one exception. The
extra-embryonal foetal tissues (yolk sac and placenta) of 14.5 day embryos
(but not other tissues from the same embryos), showed slight methylation of
several sites (nos. 3-5 of the MspI and nos. 3-7 of the HhaI sites) (Fig.
4). The endogenous murine Thy-1.2 gene showed an unmethylated island both
in foetal, including extra-embryonal and in postnatal tissues (not shown).
Thus, the MFI of the endogenous gene was also fully unmethylated in the
extra-embryonal tissues (yolk sac and placenta) in contrast to the result
observed for the introduced gene construct.
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Correlation of expression of Thy-i antigen and methylation of the gene
Normally brain and thymocytes of the adult mouse and only
brain of man are the major tissues of Thy-1 expression (5).
Using Si nuclease protection (25) assays with probes from the
ApaI site in the fourth exon, we measured the RNA levels originating from
the endogenous and the transgenic Thy-1 gene. Fig. 5 shows that high levels
of transgenic transcript in Tg12 mice are present in brain and thymus, as
represented by the 165nt (major polyA site) and the 400nt (minor polyA
site) protected fragments. The transgene is, however, not expressed in
spleen (Fig. 5, lane 3) or in other Thy-1 negative tissues (not shown). The
endogenous gene is represented by a 115nt protected fragment (only one
major polyA site) which is present in brain, thymus and spleen (Fig. 5
inset), but not in other Thy-1 negative tissues (not shown). The other
transgenic mice show the same pattern of expression, although the levels of
Thy-1 transcripts are different (15). The spleen result is somewhat
surprising and a detailed analysis indicates that the absence/presence of a
positive/negative regulatory element might be responsible for the
difference observed between the endogenous and the transgene (15). On the
other hand, the tissue-specific expression in brain and thymus indicates
that most of the control elements for specific expression are present in
the construct. The expression pattern of the transgene in the different
tissues (including spleen) indicates that although the presence of the MFI
might be a necessary requirement for expression, the maintenance or
formation of an island is not related to active expression.
DISCUSSION
The murine and human Thy-1 genes both have methylation-free
islands in their 5' ends as evidenced by the unhindered cleavage by HpaII
and HhaI of all potentially susceptible sites in this region. The island
extends over about 1.6kb in the mouse, covering exons Ia and Ib and about
600 bases upstream and downstream, and is well within the typical size
range for such islands (2).
The mouse-human hybrid gene used to establish the transgenic
mice was injected into eggs in a non-methylated state. It was subsequently
methylated to a pattern that is essentially the same as that of the
endogenous mouse Thy-1 gene, i.e. methylated sequences flank an MFI
containing promoter sequences. We do not know at what stage this
methylation took place. This result is highly reproducible in different
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mice, i.e. the maintenance of the methylation-free island, as well as the
methylation pattern of the human part of the gene construct is independent
of the (presumably random) site(s) of insertion in the murine genome, and
the number of genes in the integrated multimer. Moreover, although we do
not know its importance, MspI/HpaII site 13 is never methylated. This
implies that the information necessary to maintain these patterns lies
within the injected gene itself and might even be an intrinsic property of
OG-rich DNA in eukaryotic cells. It is perhaps interesting to note in this
respect that the H-2K gene which normally contains an MFI iB expressed and
remains unmethylated in F9 teratocarcinoma cells, while the pBR vector with
a normal OG frequency is not expressed and becomes at least partially
mathylated (16 and unpublished).
It has been suggested (3) that methylation-free islands
distinguish regions of the genome available for interaction with nuclear
factors in all cells, a property that would relate, in particular, to
house-keeping genes. Genes that are expressed in a highly tissue-specific
manner are thought not to be regularly associated with such CpG-rich,
non-methylated sequences and be part of the (methylated) bulk of the DNA.
However, the Thy-1 antigen is expressed in a highly tissue-specific manner
(5), but the methylation-free island was found in all tissues, irrespective
of whether the antigen was expressed or not. Other examples are collagen II
and a-globin (3), which clearly shows that MFI are not necessarily related
to "house-keeping" genes. A second possibility is that MFI's are related
to constitutively transcribed genes, which might be regulated in different
tissues by transcriptional enhancement and RNA stability. However, Thy-1
INA run-off studies on nuclei from various mouse tissues exclude the
possibility that transcription of a highly unstable RNA takes place in
non-expressing tissues (15). This leaves the possibility that an MFI could
constitutively bind common transcription factors, which might initiate
transcription from constitutive promoters (such as the HPRT gene), but not
from tissue-specific promoters such as Thy-1 promoters. Such promoters
would need additional tissue specific factor(s) or chromatin alterations to
activate (measurable) transcription in a tissue specific manner. DNA
methylation in the bulk of the DNA might simply serve to prevent the
binding of common factors, allowing the cell to use a limited amount of
factors. On the other hand, tissue specific factors would not be prevented
from binding and could activate methylated genes (such as globin genes) to
transcribe and become unmethylated as a consequence. The opposite situation
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i.e. methylation of an MFI clearly might play a role in the inactivation of
a gene, as shown for the HPRT gene on the inactive X chromosome (17).
Similar observations have been made for in vitro methylated genes in
transfected cells (18-22). It is unknown whether methylation of the Thy-1
gene would inhibit transcription in the appropriate tissues, i.e. our
results are consistent with a role for the methylation free island as a
permissive and possibly necessary, but not sufficient, condition for
transcription of the gene.
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